Microinvasive Targeted Combination Therapy (MTCT) is the most quickly and effective way currently to cure Multidrug-resistant pulmonary Tuberculosis around the world

Microinvasive Targeted Combination Therapy (MTCT) is the most quickly and effective way currently to cure Multidrug-resistant pulmonary Tuberculosis around the world

Yushan Yang Email: 1025859866@qq.com

As we know，tuberculosis is very serious infectious disease that threatens people’s health in the world，especially multidrug-resistant pulmonary tuberculosiswhich leads the traditional therapy trapped in the hopeless way.

Our researchaims at curing multidrug-resistant pulmonary tuberculosis ,we invent a new therapy called Microinvasive Targeted Combination Therapy (MTCT). We summed up the general idea of the therapy, the essence of the theory，as well as comparison with other therapies through the introduction of 4000 cases and 16 typical cases. and then getting out the important conclusions is that MTCT is the most quickly and effective way currently to cure multidrug-resistant pulmonary tuberculosis around the world．

Introduction to MTCT

MTCT is to use the compound anti-TB medicineinjecting it into the TB focus through skin to the lung according to Computerized Tomography (CT) dimensionally, then aided with nutrition, movement, physical and mental treatment at the same time to cure the disease in one operation.

This is the best way to cure TB because it costs little, has little risk of relapse, and can cure all kinds of tuberculosis, such as pleuritis and pulmonary tuberculosis cavity, and it is just as easy to treat general disease for this special MTCT. It just requires a simple operation, and it is easy to study and perform.

To calculate the distances between the focus and the presternal notch of the crest,then find the nearest place to inject anti-TB drugs into the lung assisted by local anesthesia with potentiated anesthesia or medication via placing tube.

2. Short term curing, fast effective, and low cost. One month curing for very early

patients, 4-5 times MTCT is OK. Patients with multidrug-resistant need only 3 periods of treatment and each for no more than 5 injections.

3. Completed individual treatment: every patient should only be treated according to his own case and drugs are confirmed through his microorganism check.

4 .Tube induced injection can draw the sanies, caseous necrosis and substances from the decayed bacterium so as to clean the cavity to relieve the symptoms of the patient the drugs can reach the focus well can make the bacteria better.

5. To avoid taking drugs for a long time, especially injuries to the digestive duct, liver and kidneysMicroinvasive Targeted Combination Therapy (MTCT) can keep the patients in good condition and increase drug tolerance.

6 .Just with simple methods and materials Microinvasive Targeted Combination Therapy (MTCT) can be easily popularized. It is located accurately, easily done, safe and reliable, and can be accepted by all patients and their families.

Adaptation diseases for MTCT

1. Adapted for patients of multidrug-resistant;

2. Adapted for those patients who have just a limited time to treat the disease;

3. Adapted for those who can not take drugs all the time.

4. Adapted for those who have serious injury to their liver and/or kidneys;

5. Adapted to those who have serious complicated diseases, take massive hemoptysis for example.

6.Adapted to those who have serious complicated disease, take pneumonoconiosis and polyinfection with fungi as examples.

7. Adapted to those who have tuberculosis empyema, pulmonary vein and bronchopleural fistula.

8. Adapted to those who have tuberculosis meningitis, lymphatic tuberculosis and bone tuberculosis.